Coronavirus Vaccine Appears Safe in the First Human Trial: The Lancet
First coronavirus vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to create an immune response against SARS-CoV-2 in humans, reports a new study.
No comments:
Post a Comment